½ÃÀ庸°í¼­
»óǰÄÚµå
1513774

¼¼°èÀÇ Ã·´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Advanced Infusion Systems Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 177 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 84¾ï 4,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 178¾ï 5,000¸¸ ´Þ·¯ ±Ùó ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, ¿¹Ãø ±â°£ µ¿¾ÈÀÇ º¹ÇÕ ¿¬°£ ¼ºÀå·ü(CAGR) 8.68%ÀÔ´Ï´Ù.

÷´Ü ÁÖÀÔ ½Ã½ºÅÛÀº ¾à¹°, ¿µ¾çÁ¦, Ç÷¾× Á¦Á¦ µîÀÇ ¾×ü¸¦ Á¦¾îµÈ ¹æ½ÄÀ¸·Î ȯÀÚÀÇ Ç÷·ù·Î Á÷Á¢ Àü´ÞÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡´Â ÇÁ·Î±×·¡¹Ö °¡´ÉÇÑ ÁÖÀÔ ÆßÇÁ, ½º¸¶Æ® µå¸³ ¼¼Æ®, À¯·®À» ¸ð´ÏÅ͸µ ¹× Á¶Á¤ÇÏ´Â ¼ÒÇÁÆ®¿þ¾î µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½Ã½ºÅÛÀº Á¤È®ÇÑ Åõ¿©¸¦ º¸ÀåÇϰí, Åõ¾à ½Ç¼öÀÇ À§ÇèÀ» ÁÙÀ̰í, ÁÖÀÔ ¿ä¹ýÀ» Á¤È®ÇÏ°Ô Á¦¾îÇÔÀ¸·Î½á ȯÀÚ °ü¸®¸¦ Çâ»ó½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº º´¿ø, ¿Ü·¡ Ŭ¸®´Ð, ÀçÅÃÄ¡·á µî ´Ù¾çÇÑ ÀÓ»ó ÇöÀå¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ ºÎ´ã Áõ°¡¿Í Á¤È®Çϰí ÅëÁ¦ µÈ ¾à¹° Àü´Þ ¹æ¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °ßÀεǰí ÀÖ½À´Ï´Ù. ´ç´¢º´, ¾Ï, ½ÉÇ÷°ü Áúȯ µîÀÇ ÀÌȯÀ²ÀÌ »ó½ÂÇÔ¿¡ µû¶ó È¿°úÀûÀÎ ÁÖÀÔ ¿ä¹ýÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÷´Ü ÁÖÀÔ ½Ã½ºÅÛÀº Á¤È®¼º, ¾ÈÀü¼º ¹× ȯÀÚÀÇ Æí¾ÈÇÔ¿¡ Å« ÀÌÁ¡À» Á¦°øÇϸç Çö´ë ÀÇ·á ȯ°æ¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú Á¶Á¤ ¼ÒÇÁÆ®¿þ¾î¸¦ ÅëÇÕÇÑ ½º¸¶Æ®ÆÊÇÁÀÇ °³¹ß µî, ÁÖÀÔ ÆßÇÁÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Àα¸ÀÇ °í·ÉÈ­¿Í ÀÌ¿¡ µû¸¥ ³ëÈ­¿Í °ü·ÃµÈ °Ç°­»óÅ Áõ°¡µµ ½ÃÀå ¼ºÀå Áõ°¡¿¡ ±â¿©ÇÕ´Ï´Ù.

ÀçÅÃÄ¡·á ¹× ¿Ü·¡ ȯÀÚ ÄÉ¾î ¼­ºñ½º·ÎÀÇ À̵¿µµ ÈÞ´ë¿ëÀ¸·Î »ç¿ëÇϱ⠽¬¿î ÁÖÀÔ ÀåÄ¡ÀÇ Ã¤¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÁÖÀÔ ¿ä¹ý¿¡ ´ëÇÑ À¯¸®ÇÑ »óȯ Á¤Ã¥Àº ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. °Ô´Ù°¡ ÀÇ·á ÀÎÇÁ¶ó °³¼±¿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Í, ÀÇ·á Á¾»çÀÚ¿Í È¯ÀÚ »çÀÌ¿¡¼­ ÷´Ü ÁÖÀÔ ±â¼úÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ½ÃÀåÀ» ÀüÁø½ÃŰ´Â ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü ÁÖÀÔ ½Ã½ºÅÛÀÇ ºñ¿ëÀÌ ³ô°í ÀÇ·á Á¾»çÀÚÀÇ Ã¶ÀúÇÑ ±³À°ÀÌ ÇÊ¿äÇÏ´Ù´Â °ÍÀº ÇâÈÄ ¼ö³â°£ ½ÃÀå ¼ºÀåÀÇ °úÁ¦°¡ µÉ ¼ö ÀÖ½À´Ï´Ù.

Á¶»ç º¸°í¼­´Â Æ÷ÅÍÀÇ Five Force ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. °Ô´Ù°¡, ÀÌ·¯ÇÑ µµ±¸´Â ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Á¢±Ù¹ýÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ ÇâÈÄ ±âȸ¿Í ÇÔ²² °¢ Á¦Ç° ¹× ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù.

Á¦Ç°º°

  • ȯÀÚ Á¦¾î ÁøÅë ÆßÇÁ
  • ¿ë·®½Ä ÁÖÀÔ ½Ã½ºÅÛ
  • ÁÖ»ç±â ÁÖÀÔ ½Ã½ºÅÛ
  • ¿Ü·¡¿ë ÁÖÀÔ ½Ã½ºÅÛ
  • ÀÏȸ¿ë ÁÖÀÔ ½Ã½ºÅÛ
  • ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ½Ã½ºÅÛ
  • ¸Å¸³Çü ÁÖÀÔ ½Ã½ºÅÛ

¿ëµµº°

  • ´ç´¢º´
  • õ½Ä
  • È­Çпä¹ý
  • ÅëÁõ °ü¸®
  • ÀÓ»ó¿µ¾ç

ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ħ´ë »çÀ̵å
  • º´¿ø
  • Áø´Ü¼¾ÅÍ

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ã·´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, Àú¸íÇÑ ¸ðµç Áö¿ª¿¡¼­ÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä,ÃßÁ¤µÇ¸ç¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì Google¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ÇöȲ

Á¦3Àå ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ : »ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü À϶÷
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀ̾î À϶÷
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • Á¦Ç°º° °³¿ä
  • Á¦Ç°º° °ú°Å,¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ȯÀÚ Á¦¾î ÁøÅë ÆßÇÁ
  • ¿ë·®½Ä ÁÖÀÔ ½Ã½ºÅÛ
  • ÁÖ»ç±â ÁÖÀÔ ½Ã½ºÅÛ
  • ¿Ü·¡¿ë ÁÖÀÔ ½Ã½ºÅÛ
  • ÀÏȸ¿ë ÁÖÀÔ ½Ã½ºÅÛ
  • ¿¤¶ó½ºÅä¸Ó ÁÖÀÔ ½Ã½ºÅÛ
  • ¸Å¸³Çü ÁÖÀÔ ½Ã½ºÅÛ

Á¦6Àå ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ¿ëµµº° °ú°Å,¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ´ç´¢º´
  • õ½Ä
  • È­Çпä¹ý
  • ÅëÁõ °ü¸®
  • ÀÓ»ó¿µ¾ç

Á¦7Àå ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÃÖÁ¾ »ç¿ëÀÚº° °³¿ä
  • ÃÖÁ¾ »ç¿ëÀÚº° °ú°Å,¿¹Ãø µ¥ÀÌÅÍ ºÐ¼®
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ħ´ë »çÀ̵å
  • º´¿ø
  • Áø´Ü¼¾ÅÍ

Á¦8Àå ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹º° À϶÷
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ±â¾÷°æÀï ±¸µµ

  • ÷´Ü ÁÖÀÔ ½Ã½ºÅÛ ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ,Çù·Â,°è¾à
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Hospira Inc.
  • Animas Corporation
  • Terumo Corporation
  • F.Hoffmann-La Roche Ltd.
  • AngioDynamics Inc.
  • B. Braun Melsungen AG
BJH 24.07.25

The global demand for Advanced Infusion Systems Market is presumed to reach the market size of nearly USD 17.85 Billion by 2032 from USD 8.44 Billion in 2023 with a CAGR of 8.68% under the study period 2024-2032.

Advanced infusion systems are medical devices used to deliver fluids, such as medications, nutrients, and blood products, directly into a patient's bloodstream in a controlled manner. These systems include programmable infusion pumps, smart intravenous (IV) sets, and software for monitoring and adjusting flow rates. They enhance patient care by ensuring accurate dosing, reducing the risk of medication errors, and allowing for precise control of infusion therapy. These systems are vital in various clinical settings, including hospitals, outpatient clinics, and home care.

MARKET DYNAMICS

The advanced infusion systems market is driven by the rising burden of chronic diseases and the growing demand for precise and controlled drug delivery methods. As the incidence of conditions like diabetes, cancer, and cardiovascular diseases rises, the need for effective infusion therapies becomes more critical. Advanced infusion systems offer significant accuracy, safety, and patient comfort benefits, making them indispensable in modern healthcare settings. Technological advancements in infusion pumps, such as developing smart pumps with integrated real-time monitoring and adjustment software, further drive market growth. The aging population and the subsequent increase in age-related health conditions also contribute to the rising market growth.

The shift towards home healthcare and outpatient care services also boosts the adoption of portable and user-friendly infusion devices. Government initiatives and favorable reimbursement policies for infusion therapies are crucial in promoting market growth. Moreover, the increasing focus on improving healthcare infrastructure and the growing awareness about the benefits of advanced infusion technologies among healthcare providers and patients drive the market forward. However, the high cost of advanced infusion systems and the requirement for thorough training of healthcare professionals may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Advanced Infusion Systems. The growth and trends of Advanced Infusion Systems industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Advanced Infusion Systems market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Patient-Controlled Analgesia Pump
  • Volumetric Infusion System
  • Syringe Infusion System
  • Ambulatory Infusion System
  • Disposable Infusion System
  • Elastomeric Infusion System
  • Implantable Infusion System

By Application

  • Diabetes
  • Asthma
  • Chemotherapy
  • Pain Management
  • Clinical Nutrition

By End-User

  • Ambulatory Surgical Centers
  • Bedside
  • Hospitals
  • Diagnostic Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Advanced Infusion Systems market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Advanced Infusion Systems market include Hospira Inc., Animas Corporation, Terumo Corporation, F.Hoffmann-La Roche Ltd., AngioDynamics Inc., B.Braun Melsungen AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ADVANCED INFUSION SYSTEMS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Patient-Controlled Analgesia Pump Historic and Forecast Sales By Regions
  • 5.4. Volumetric Infusion System Historic and Forecast Sales By Regions
  • 5.5. Syringe Infusion System Historic and Forecast Sales By Regions
  • 5.6. Ambulatory Infusion System Historic and Forecast Sales By Regions
  • 5.7. Disposable Infusion System Historic and Forecast Sales By Regions
  • 5.8. Elastomeric Infusion System Historic and Forecast Sales By Regions
  • 5.9. Implantable Infusion System Historic and Forecast Sales By Regions

6. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY APPLICATION

  • 6.1. Overview By Application
  • 6.2. Historical and Forecast Data Analysis By Application
  • 6.3. Diabetes Historic and Forecast Sales By Regions
  • 6.4. Asthma Historic and Forecast Sales By Regions
  • 6.5. Chemotherapy Historic and Forecast Sales By Regions
  • 6.6. Pain Management Historic and Forecast Sales By Regions
  • 6.7. Clinical Nutrition Historic and Forecast Sales By Regions

7. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY END-USER

  • 7.1. Overview By End-User
  • 7.2. Historical and Forecast Data Analysis By End-User
  • 7.3. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 7.4. Bedside Historic and Forecast Sales By Regions
  • 7.5. Hospitals Historic and Forecast Sales By Regions
  • 7.6. Diagnostic Centers Historic and Forecast Sales By Regions

8. GLOBAL ADVANCED INFUSION SYSTEMS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2 North America By Segment Sales Analysis
    • 8.3.3 North America By Country Sales Analysis
    • 8.3.4 United States Sales Analysis
    • 8.3.5 Canada Sales Analysis
    • 8.3.6 Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2 Europe By Segment Sales Analysis
    • 8.4.3 Europe By Country Sales Analysis
    • 8.4.4 United Kingdom Sales Analysis
    • 8.4.5 France Sales Analysis
    • 8.4.6 Germany Sales Analysis
    • 8.4.7 Italy Sales Analysis
    • 8.4.8 Russia Sales Analysis
    • 8.4.9 Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2 Asia Pacific By Segment Sales Analysis
    • 8.5.3 Asia Pacific By Country Sales Analysis
    • 8.5.4 China Sales Analysis
    • 8.5.5 India Sales Analysis
    • 8.5.6 Japan Sales Analysis
    • 8.5.7 South Korea Sales Analysis
    • 8.5.8 Australia Sales Analysis
    • 8.5.9 South East Asia Sales Analysis
    • 8.5.10 Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2 Latin America By Segment Sales Analysis
    • 8.6.3 Latin America By Country Sales Analysis
    • 8.6.4 Brazil Sales Analysis
    • 8.6.5 Argentina Sales Analysis
    • 8.6.6 Peru Sales Analysis
    • 8.6.7 Chile Sales Analysis
    • 8.6.8 Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2 Middle East & Africa By Segment Sales Analysis
    • 8.7.3 Middle East & Africa By Country Sales Analysis
    • 8.7.4 Saudi Arabia Sales Analysis
    • 8.7.5 UAE Sales Analysis
    • 8.7.6 Israel Sales Analysis
    • 8.7.7 South Africa Sales Analysis
    • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ADVANCED INFUSION SYSTEMS COMPANIES

  • 9.1. Advanced Infusion Systems Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10. COMPANY PROFILES OF ADVANCED INFUSION SYSTEMS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Hospira Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Revenue
    • 10.3.3 Products
    • 10.3.4 Recent Developments
  • 10.4. Animas Corporation
    • 10.4.1 Company Overview
    • 10.4.2 Company Revenue
    • 10.4.3 Products
    • 10.4.4 Recent Developments
  • 10.5. Terumo Corporation
    • 10.5.1 Company Overview
    • 10.5.2 Company Revenue
    • 10.5.3 Products
    • 10.5.4 Recent Developments
  • 10.6. F.Hoffmann-La Roche Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Company Revenue
    • 10.6.3 Products
    • 10.6.4 Recent Developments
  • 10.7. AngioDynamics Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Company Revenue
    • 10.7.3 Products
    • 10.7.4 Recent Developments
  • 10.8. B.Braun Melsungen AG
    • 10.8.1 Company Overview
    • 10.8.2 Company Revenue
    • 10.8.3 Products
    • 10.8.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦